Name | 4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide |
---|---|
Synonyms |
6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-hydroxy-
4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-hydroxy-6-quinolinecarboxamide Lenvatinib Impurity 4 |
Description | O-Demethyl Lenvatinib is a metabolite of Lenvatinib (HY-10981). Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities[1][2]. |
---|---|
Related Catalog |
Density | 1.6±0.0 g/cm3 |
---|---|
Boiling Point | 644.1±0.0 °C at 760 mmHg |
Molecular Formula | C20H17ClN4O4 |
Molecular Weight | 412.826 |
Flash Point | 343.4±0.0 °C |
Exact Mass | 412.093842 |
LogP | 4.23 |
Vapour Pressure | 0.0±0.0 mmHg at 25°C |
Index of Refraction | 1.739 |
Water Solubility | Insuluble (6.2E-5 g/L) (25 ºC) |